SLC-0111

N/A

Report date: 2024/06/14 20:00:57
NME

Base Information

Drug NameSLC-0111
Drug Alias NameSLC-0111WBI-5111
ClassificationSmall molecules
Mechanisms of ActionCarbonic anhydrase IX inhibitors
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsSolid tumoursCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSignalchem Lifesciences CorpBritish Columbia Cancer Agency
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWelichem Biotech IncBritish Columbia Cancer AgencySignalchem Lifesciences Corp
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Pancreatic Ductal

Other Information

ATC CodeN/A
Related LinksN/A